Verified email-pattern data for Mindbio Therapeutics is currently limited. You can still use the company insights and contact sections below.
MindBio Therapeutics is a clinical stage drug development company that is pioneering psychedelic microdosing in multiple Phase 2B clinical trials.
MB22001 is MindBio's lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for safe take home microdosing. Phase 2 clinical trials are underway.
Clinical trials include:
1. Phase 2B trial in patients with Major Depressive Disorder
2. Phase 2B trial in patients with Late Stage Cancer and Depression
The Phase 2B trial in patients with Major Depressive Disorder will evaluate the effectiveness of MB22001 in treating depression. We know from an open label Phase 2A trial in 20 patients with Major Depressive Disorder, that 53% of patients with depression were in complete remission from their depression at week 8. This is represented by a 14.1 point drop in MADRS score (Montgomery-Asberg Depression Rating Scale). The 60% overall improvement in depressive symptoms and previous successful trials in healthy individuals gives the company confidence going into Phase 2B trials that MB22001 is a very promising treatment for Depression.
The Phase 2 clinical trials for cancer patients will evaluate the feasibility of conducting a randomised controlled trial comparing psychedelic-microdose assisted – Meaning Centred Psychotherapy to standard Meaning-Centred Psychotherapy in people who have advanced cancer and anxiety or depression. Participants will be randomised to receive psychotherapy alongside doses of either an LSD microdose or placebo. The feasibility, acceptability, safety and potential psychological benefits of this intervention will be assessed. Our findings will inform the development of a larger trial and provide initial indication of potential benefits of psychedelic microdosing in advanced cancer.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 91-97 William Street, Level 4,australia
- Industry
- Pharmaceutical Manufacturing
- Keywords
- Psychedelics, Clinical Trials, Drug Formulation, Wearables, Artificial Intelligence, Device Development.
- HQ
- Melbourne , Victoria
Mindbio Therapeutics Questions
MindBio Therapeutics's website is http://www.mindbiotherapeutics.com
MindBio Therapeutics's LinkedIn profile is https://au.linkedin.com/company/mindbio-therapeutics
MindBio Therapeutics has
4 employees.
View email and phone details for 4
employees at MindBio Therapeutics.
MindBio Therapeutics's industry is
Pharmaceutical Manufacturing
MindBio Therapeutics's top competitors are
Mindmed,
Cybin Inc,
Psychedelic Invest - Insights And Analyses On Psychedelics,
Atai Life Sciences,
Delix Therapeutics,
Enveric Biosciences, Inc.,
Compass Pathways,
Mycomedica Life Sciences, Pbc,
Beckley Psytech,
Pharmala Biotech Inc. (Mdma.cse).
MindBio Therapeutics's categories are Pharmaceutical Manufacturing
MindBio Therapeutics's founding year is 2021
Explore related pages
Related company profiles:
Top MindBio Therapeutics Employees
-
15ive15ifteen.com
1 +141648XXXXX
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.